The effect of nicotine on murine CD4 T cell responses

https://doi.org/10.1016/S0192-0561(96)00054-9Get rights and content

Abstract

T cells were exposed to various concentrations of nicotine or smokeless tobacco extract (STE) during in vitro immune responses in order to examine effects upon expression of T cell costimulatory counter-receptors, CD28 and CTLA-4, and cytokine production. Splenic mononuclear cells (SPM) were exposed to 1:102 to 1:103 dilutions of STE or 1–100 μg/ml nicotine during 48 and 72h of stimulation with anti-CD3. Expression of CD28 and CTLA-4 was evaluated with flow cytometry and production and expression of IL-2, IL-4, IL-10 and IFN-γ were evaluated using ELISA and RT-PCR. The data here indicate that the percentage of CD4+ T cells expressing CD28 declined while percentage and intensity of CTLA-4 expression increased with exposure to a 1:102 dilution of STE during the T cell response. Exposure to nicotine decreased the percentage of CD4+ T cells expressing both CD28 and CTLA-4 and decreased the intensity of CD28 expression. Responding T cells exposed to nicotine produced significantly less Thl cytokines, IL-2 and IFN-γ, but significantly more Th2 cytokines, IL-4 and IL-10. Cytokine specific mRNA expression was only slightly affected by the exposure to nicotine. Thus, exposure of T cells to physiological concentrations of STE or nicotine can alter the T cell expression of CD28 and CTLA-4, and the CD4 T cell cytokine expression pattern.

References (43)

  • G.J. Freeman et al.

    Uncovering of functional alternative CTLA-4 counter-receptor in B7-deficient mice

    Science

    (1993)
  • A.C. Fluckiger et al.

    Interleukin 10 (IL-10) upregulates functional high affinity IL-2 receptors on normal and leukemic B lymphocytes

    J. Exp. Med.

    (1993)
  • K. Fujihashi et al.

    Gingival mononuclear cells from chronic inflammatory periodontal tissues produce interleukin (IL-)-5 and IL-6 but not IL-2 and IL-4

    Am J Pathol.

    (1993)
  • K. Fujihashi et al.

    Cytokines and periodontal disease: immunopathological role of interleukins for B cell responses in chronic inflamed gingival tissues

    J. Periodontol.

    (1993)
  • R.T. Gazzinelli et al.

    HIV s Type 1 lymphokine and IL-12 responses to Toxoplasma gondii but fails to inhibit the synthesis of other parasite-induced monokines

    J. Immunol.

    (1995)
  • Y. Geng et al.

    Effects of nicotine on the immune response. II. Chronic nicotine treatment induces T cell anergy

    J. Immunol.

    (1996)
  • S. Gillis et al.

    T cell growth factor: Parameters of production and a quantitative microassay for activity

    J. Immunol.

    (1978)
  • F.A. Harding et al.

    CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones

    Nature

    (1992)
  • K.S. Hathcock et al.

    Identification of an alternative CTLA-4 ligand costimulatory for T cell activation

    Science

    (1993)
  • D. Hoffmann

    Carcinogenic tobacco specific nitrosamine in snuff and saliva of snuff dippers

    Cancer Res.

    (1985)
  • C.S. Hsieh et al.

    Development of Th1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages

    Science

    (1993)
  • Cited by (58)

    • In-vitro immunomodulatory effects of nicotine on Nitric Oxide, interleukin 1β and interleukin 37 production in human peripheral blood mononuclear cells (PBMC) from patients with Behçet disease

      2021, International Immunopharmacology
      Citation Excerpt :

      In addition, other studies demonstrate that nicotine reduces secretion of pro-inflammatory cytokines such as IL-6, TNF-α, IL-12, IL-8, and IL-1β and alters NO levels in rats’ model of MS and in cultured human cells in-vitro [54,55,56,57]. In the same line, it was shown that nicotine increases IL-10 levels produced by splenic mononuclear cells isolated from female BALB/c mice and Rat Model of Multiple Sclerosis [58,53]. Specific receptors for nicotine are present on lymphocytes from human, rat, and mouse [59,60], and its anti-inflammatory effects are mediated through the activation of the alpha7 nicotinic acetylcholine receptor (α7nAChR) located on immune cells resulting in a decrease of pro-inflammatory cytokines production, particularly TNF-α and IL-2 from human monocytes cells [61], and IL1, IL-18 from human macrophages through an inhibitory effect on NF-κB activation [54].

    • Abnormal CD161<sup>+</sup> immune cells and retinoic acid receptor–related orphan receptor γt–mediate enhanced IL-17F expression in the setting of genetic hypertension

      2017, Journal of Allergy and Clinical Immunology
      Citation Excerpt :

      In most hypertensive human subjects and animal models of hypertension, sympathetic nerve activity is exaggerated,61-63 an effect that can result in increased inflammatory responses. In contrast, the parasympathetic autonomic nervous system, through activation of α7-nAChR, exerts an anti-inflammatory effect on T cells.64-66 Activation of α7-nAChR expression on the surfaces of CD4+ T cells67 by nicotine reduces the TH17 response.68

    View all citing articles on Scopus
    View full text